Polymeric Carriers
Polymeric Carriers - Related Videos
01:24
Site-Targeted Drug Delivery Systems: Polymeric Carriers
0 Views •
2026
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24
Electron Carriers
0 Views •
2019
Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons. Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
06:45
Polymerization
0 Views •
2023
Source: Vy M. Dong and Jan Riedel, Department of Chemistry, University of California, Irvine, CA Polymers are made from macromolecules, which are composed of repeating units (the so called monomeric units). In our modern world, polymers play an important role. One of the first important polymers was nylon, which is a polyamide. It found widespread application in tooth brushes and stockings.
13:29
Biodistribution of Nano-drug Carriers: Applications of SEM
0 Views •
2023
Source: Peiman Shahbeigi-Roodposhti and Sina Shahbazmohamadi, Biomedical Engineering Department, University of Connecticut, Storrs, Connecticut Nanoparticles have been increasingly used research towards targeted drug delivery and controlled drug release. While most of these particles have been developed as polymeric or liposomal particles because of their biocompatibility, there is a trend in current research toward the use of metallic and magnetic nanoparticles. These metallic nanoparticles...
07:28
Ethylene Polymerizations Using Parallel Pressure Reactors and a Kinetic Analysis of Chain Transfer Polymerization
0 Views •
2015
A protocol for the high-throughput analysis of polymerization catalyst, chain transfer polymerizations, polyethylene characterization, and reaction kinetic analysis is presented.
FAQs
Release timing depends on how the therapeutic molecule interacts with the polymer and how the carrier changes under physiological conditions. Diffusion can permit gradual movement through the matrix, while swelling can open pathways for release. Chemical cleavage separates attached molecules, and polymer degradation can progressively alter the carrier. Selecting among these mechanisms helps align delivery with the intended clinical use.
Encapsulation and polymer attachment offer different design strategies. In a matrix, the drug is held within the polymer structure and can leave as it diffuses or as the material swells or degrades. With attachment, release requires chemical cleavage of the bond connecting the molecule to the polymer chain. This distinction helps researchers relate carrier architecture to release behavior.
Polymeric carriers can be adjusted through both polymer composition and carrier size. These variables give developers control over how a formulation is organized and how it performs as it travels through the body, without changing the therapeutic molecule itself. Such tunability is especially relevant when designing systemic, localized, or targeted treatment strategies.
Clinical selection often centers on the problem the formulation must solve. A carrier may be considered when poor drug solubility or instability limits performance, when prolonged circulation is desirable, or when reducing systemic toxicity is important. The same platform can also support localized or targeted treatment, allowing formulation goals to guide polymer choice and release design.
A basic design workflow starts by choosing a natural or synthetic polymer, then deciding whether the therapeutic molecule will be encapsulated in a matrix or attached to polymer chains. Developers next match the expected release process, such as diffusion, swelling, cleavage, or degradation, to the intended physiological setting. This sequence links carrier structure with the desired delivery purpose.
These systems are relevant across several clinical research areas because their properties can be adapted to different delivery goals. Applications identified for polymeric carriers include vaccines, oncology, gene delivery, and long-acting formulations. In each area, the rationale may involve improving stability, extending circulation, reducing systemic toxicity, or supporting localized or targeted treatment.